Virus Dataset Detail

> Detail information for each sample

Dataset Information
Accession GSE136189
Status 2020/9/1
Title Genome-wide methylation analysis of T-cells using Infinium HumanMethylation BeadChip
Organism Homo sapiens
Experiment type Methylation profiling by genome tiling array
Summary DNA methylation in T-cells.
Samples
GSM ID Sample info Characteristics Description
GSM4042256 T-cells_(CD3+/CD4+/CD7+/CADM1-)_HTLV-1 asymptomatic carrier_1 diagnosis:HTLV-1 asymptomatic carrier; cell type:T cells; gender:Female; age:55; wbc (/ul):6,300; lym (%):33.0; abn. lym (%):0.0; sil-2r (u/ml):No Data AC1_P;Clinical specimen, T-cells
GSM4042257 T-cells_(CD3+/CD4+/CD7dimly+/CADM1+)_HTLV-1 asymptomatic carrier_1 diagnosis:HTLV-1 asymptomatic carrier; cell type:T cells; gender:Female; age:55; wbc (/ul):6,300; lym (%):33.0; abn. lym (%):0.0; sil-2r (u/ml):No Data AC1_D;Clinical specimen, T-cells
GSM4042258 T-cells_(CD3+/CD4+/CD7-/CADM1+)_HTLV-1 asymptomatic carrier_1 diagnosis:HTLV-1 asymptomatic carrier; cell type:T cells; gender:Female; age:55; wbc (/ul):6,300; lym (%):33.0; abn. lym (%):0.0; sil-2r (u/ml):No Data AC1_N;Clinical specimen, T-cells
GSM4042259 T-cells_(CD3+/CD4+/CD7+/CADM1-)_HTLV-1 asymptomatic carrier_2 diagnosis:HTLV-1 asymptomatic carrier; cell type:T cells; gender:Male; age:83; wbc (/ul):4,600; lym (%):36.5; abn. lym (%):2.5; sil-2r (u/ml):598 AC2_P;Clinical specimen, T-cells
GSM4042260 T-cells_(CD3+/CD4+/CD7-/CADM1+)_HTLV-1 asymptomatic carrier_2 diagnosis:HTLV-1 asymptomatic carrier; cell type:T cells; gender:Male; age:83; wbc (/ul):4,600; lym (%):36.5; abn. lym (%):2.5; sil-2r (u/ml):598 AC2_N;Clinical specimen, T-cells
GSM4042261 T-cells_(CD3+/CD4+/CD7+/CADM1-)_HTLV-1 asymptomatic carrier_3 diagnosis:HTLV-1 asymptomatic carrier; cell type:T cells; gender:Male; age:59; wbc (/ul):7,300; lym (%):36.0; abn. lym (%):4.0; sil-2r (u/ml):530 AC3_P;Clinical specimen, T-cells
GSM4042262 T-cells_(CD3+/CD4+/CD7dimly+/CADM1+)_HTLV-1 asymptomatic carrier_3 diagnosis:HTLV-1 asymptomatic carrier; cell type:T cells; gender:Male; age:59; wbc (/ul):7,300; lym (%):36.0; abn. lym (%):4.0; sil-2r (u/ml):530 AC3_D;Clinical specimen, T-cells
GSM4042263 T-cells_(CD3+/CD4+/CD7-/CADM1+)_HTLV-1 asymptomatic carrier_3 diagnosis:HTLV-1 asymptomatic carrier; cell type:T cells; gender:Male; age:59; wbc (/ul):7,300; lym (%):36.0; abn. lym (%):4.0; sil-2r (u/ml):530 AC3_N;Clinical specimen, T-cells
GSM4042264 T-cells_(CD3+/CD4+/CD7+/CADM1-)_smoldering ATL_3 diagnosis:Smoldering ATL; cell type:T cells; gender:Female; age:72; wbc (/ul):4,500; lym (%):37.0; abn. lym (%):13.5; sil-2r (u/ml):622 S3_P;Clinical specimen, T-cells
GSM4042265 T-cells_(CD3+/CD4+/CD7dimly+/CADM1+)_smoldering ATL_3 diagnosis:Smoldering ATL; cell type:T cells; gender:Female; age:72; wbc (/ul):4,500; lym (%):37.0; abn. lym (%):13.5; sil-2r (u/ml):622 S3_D;Clinical specimen, T-cells
GSM4042266 T-cells_(CD3+/CD4+/CD7-/CADM1+)_smoldering ATL_3 diagnosis:Smoldering ATL; cell type:T cells; gender:Female; age:72; wbc (/ul):4,500; lym (%):37.0; abn. lym (%):13.5; sil-2r (u/ml):622 S3_N;Clinical specimen, T-cells
GSM4042267 T-cells_(CD3+/CD4+/CD7+/CADM1-)_chronic ATL_1 diagnosis:Chronic ATL; cell type:T cells; gender:Female; age:78; wbc (/ul):14,600; lym (%):17.5; abn. lym (%):45.0; sil-2r (u/ml):1,719 C1_P;Clinical specimen, T-cells
GSM4042268 T-cells_(CD3+/CD4+/CD7dimly+/CADM1+)_chronic ATL_1 diagnosis:Chronic ATL; cell type:T cells; gender:Female; age:78; wbc (/ul):14,600; lym (%):17.5; abn. lym (%):45.0; sil-2r (u/ml):1,719 C1_D;Clinical specimen, T-cells
GSM4042269 T-cells_(CD3+/CD4+/CD7-/CADM1+)_chronic ATL_1 diagnosis:Chronic ATL; cell type:T cells; gender:Female; age:78; wbc (/ul):14,600; lym (%):17.5; abn. lym (%):45.0; sil-2r (u/ml):1,719 C1_N;Clinical specimen, T-cells
GSM4042270 T-cells_(CD3+/CD4+/CD7+/CADM1-)_chronic ATL_2 diagnosis:Chronic ATL; cell type:T cells; gender:Female; age:64; wbc (/ul):9,200; lym (%):54.2; abn. lym (%):11.0; sil-2r (u/ml):851 C2_P;Clinical specimen, T-cells
GSM4042271 T-cells_(CD3+/CD4+/CD7-/CADM1+)_chronic ATL_2 diagnosis:Chronic ATL; cell type:T cells; gender:Female; age:64; wbc (/ul):9,200; lym (%):54.2; abn. lym (%):11.0; sil-2r (u/ml):851 C2_N;Clinical specimen, T-cells
GSM4042272 T-cells_(CD3+/CD4+/CD7+/CADM1-)_chronic ATL_3 diagnosis:Chronic ATL; cell type:T cells; gender:Male; age:62; wbc (/ul):9,740; lym (%):28.0; abn. lym (%):23.0; sil-2r (u/ml):2,120 C3_P;Clinical specimen, T-cells
GSM4042273 T-cells_(CD3+/CD4+/CD7dimly+/CADM1+)_chronic ATL_3 diagnosis:Chronic ATL; cell type:T cells; gender:Male; age:62; wbc (/ul):9,740; lym (%):28.0; abn. lym (%):23.0; sil-2r (u/ml):2,120 C3_D;Clinical specimen, T-cells
GSM4042274 T-cells_(CD3+/CD4+/CD7-/CADM1+)_chronic ATL_3 diagnosis:Chronic ATL; cell type:T cells; gender:Male; age:62; wbc (/ul):9,740; lym (%):28.0; abn. lym (%):23.0; sil-2r (u/ml):2,120 C3_N;Clinical specimen, T-cells
GSM4042275 T-cells_(CD3+/CD4+/CD7+/CADM1-)_chronic ATL_4 diagnosis:Chronic ATL; cell type:T cells; gender:Female; age:51; wbc (/ul):3,770; lym (%):56.0; abn. lym (%):9.0; sil-2r (u/ml):1,570 C4_P;Clinical specimen, T-cells
GSM4042276 T-cells_(CD3+/CD4+/CD7dimly+/CADM1+)_chronic ATL_4 diagnosis:Chronic ATL; cell type:T cells; gender:Female; age:51; wbc (/ul):3,770; lym (%):56.0; abn. lym (%):9.0; sil-2r (u/ml):1,570 C4_D;Clinical specimen, T-cells
GSM4042277 T-cells_(CD3+/CD4+/CD7-/CADM1+)_chronic ATL_4 diagnosis:Chronic ATL; cell type:T cells; gender:Female; age:51; wbc (/ul):3,770; lym (%):56.0; abn. lym (%):9.0; sil-2r (u/ml):1,570 C4_N;Clinical specimen, T-cells
GSM4042278 T-cells_(CD3+/CD4+/CD7-/CADM1+)_acute ATL_1 diagnosis:Acute ATL; cell type:T cells; gender:Male; age:83; wbc (/ul):15,840; lym (%):3.0; abn. lym (%):63.0; sil-2r (u/ml):62,100 A1_N;Clinical specimen, T-cells
GSM4042279 T-cells_(CD3+/CD4+/CD7-/CADM1+)_acute ATL_2 diagnosis:Acute ATL; cell type:T cells; gender:Female; age:67; wbc (/ul):89,900; lym (%):Unmeasurable; abn. lym (%):89.0; sil-2r (u/ml):43,694 A2_N;Clinical specimen, T-cells
GSM4042280 T-cells_(CD3+/CD4+/CD7-/CADM1+)_acute ATL_3 diagnosis:Acute ATL; cell type:T cells; gender:Male; age:80; wbc (/ul):68,800; lym (%):Unmeasurable; abn. lym (%):82.5; sil-2r (u/ml):85,528 A3_N;Clinical specimen, T-cells
GSM4042281 HTLV-1-infected cell line_MT-1 cell line:MT-1; cell type:T cells MT-1;Cell line, T-cells
GSM4042282 HTLV-1-infected cell line_MT-2 cell line:MT-2; cell type:T cells MT-2;Cell line, T-cells
GSM4042283 HTLV-1-infected cell line_ATN-1 cell line:ATN-1; cell type:T cells ATN-1;Cell line, T-cells
GSM4042284 HTLV-1-infected cell line_ST-1 cell line:ST-1; cell type:T cells ST-1;Cell line, T-cells
GSM4042285 HTLV-1-infected cell line_KOB cell line:KOB; cell type:T cells KOB;Cell line, T-cells
GSM4042286 HTLV-1-infected cell line_KK-1 cell line:KK-1; cell type:T cells KK-1;Cell line, T-cells
GSM4042287 T-cells_(CD3+/CD4+/CD7+/CADM1-)_smoldering ATL_1 diagnosis:Smoldering ATL; cell type:T cells; gender:Female; age:57; wbc (/ul):7,100; lym (%):11.0; abn. lym (%):35.5; sil-2r (u/ml):No Data S1_P;Clinical specimen, T-cells
GSM4042288 T-cells_(CD3+/CD4+/CD7dimly+/CADM1+)_smoldering ATL_1 diagnosis:Smoldering ATL; cell type:T cells; gender:Female; age:57; wbc (/ul):7,100; lym (%):11.0; abn. lym (%):35.5; sil-2r (u/ml):No Data S1_D;Clinical specimen, T-cells
GSM4042289 T-cells_(CD3+/CD4+/CD7-/CADM1+)_smoldering ATL_1 diagnosis:Smoldering ATL; cell type:T cells; gender:Female; age:57; wbc (/ul):7,100; lym (%):11.0; abn. lym (%):35.5; sil-2r (u/ml):No Data S1_N;Clinical specimen, T-cells
GSM4042290 T-cells_(CD3+/CD4+/CD7+/CADM1-)_smoldering ATL_2 diagnosis:Smoldering ATL; cell type:T cells; gender:Male; age:85; wbc (/ul):5,300; lym (%):29.5; abn. lym (%):6.0; sil-2r (u/ml):No Data S2_P;Clinical specimen, T-cells
GSM4042291 T-cells_(CD3+/CD4+/CD7dimly+/CADM1+)_smoldering ATL_2 diagnosis:Smoldering ATL; cell type:T cells; gender:Male; age:85; wbc (/ul):5,300; lym (%):29.5; abn. lym (%):6.0; sil-2r (u/ml):No Data S2_D;Clinical specimen, T-cells
GSM4042292 T-cells_(CD3+/CD4+/CD7-/CADM1+)_smoldering ATL_2 diagnosis:Smoldering ATL; cell type:T cells; gender:Male; age:85; wbc (/ul):5,300; lym (%):29.5; abn. lym (%):6.0; sil-2r (u/ml):No Data S2_N;Clinical specimen, T-cells
GSM4042253 T-cells_(CD3+/CD4+/CD7+/CADM1-)_healthy volunteer_1 diagnosis:Healthy; cell type:T cells; gender:Male; age:31; wbc (/ul):No Data; lym (%):No Data; abn. lym (%):No Data; sil-2r (u/ml):No Data HC1_P;Clinical specimen, T-cells
GSM4042254 T-cells_(CD3+/CD4+/CD7+/CADM1-)_healthy volunteer_2 diagnosis:Healthy; cell type:T cells; gender:Female; age:37; wbc (/ul):No Data; lym (%):No Data; abn. lym (%):No Data; sil-2r (u/ml):No Data HC2_P;Clinical specimen, T-cells
GSM4042255 T-cells_(CD3+/CD4+/CD7+/CADM1-)_healthy volunteer_3 diagnosis:Healthy; cell type:T cells; gender:Male; age:31; wbc (/ul):No Data; lym (%):No Data; abn. lym (%):No Data; sil-2r (u/ml):No Data HC3_P;Clinical specimen, T-cells
Platform GPL13534  GPL23976  : Illumina HumanMethylation450 BeadChip (HumanMethylation450_15017482);Illumina Infinium HumanMethylation850 BeadChip
Literature   
Download Download Methylation Analysis Data